AVBP vs. SMH

In the year-to-date period, AVBP achieves a -21.17% return, which is significantly lower than SMH's 0.79% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for ArriVent BioPharma Inc. Common Stock (AVBP) and VanEck Vectors Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AVBP Sharpe Ratio is 0.23, which is higher than the SMH Sharpe Ratio of -0.00. The chart below compares the historical Sharpe Ratios of AVBP and SMH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

AVBP has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.44%.

The maximum AVBP drawdown since its inception was -54.25%, smaller than the maximum SMH drawdown of -83.29%. Use the drawdown chart below to compare losses from any high point for AVBP and SMH.

ArriVent BioPharma Inc. Common Stock (AVBP) has a higher volatility of 13.38% compared to VanEck Vectors Semiconductor ETF (SMH) at 8.70%. This indicates that AVBP's price experiences larger fluctuations and is considered to be riskier than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.